FMC ACO

Accountable Care Organizations Public Reporting Information

  • ACO Name & Location

  • Florida Medical Clinic ACO, LLC

    38135 Market Square

    Zephyrhills, FL 33542

  • ACO Primary Contact

  • Judyth Miranda, ARNP,

    Florida Medical Clinic, PA

    Director of Accountable

    Care Organization

    jmiranda@floridamedicalclinic.com

    813.712.1645

  • Organizational Information

  • ACO Participants

    Florida Medical Clinic, PA

    FMC Urgent Care, LLC

  • ACO Participants in Joint Ventures between ACO Professionals and Hospitals

  • No participants are involved in a joint venture between ACO professionals and hospitals.

  • ACO Governing Body

  • Chandresh Saraiya, MD
    Chairman
    Voting member
    ACO Participant Representative, FMC
  • Emilio Dominguez, MD
    Voting member
    ACO Participant Representative, FMC
  • Joe Cozzolino, MD
    Voting member
    ACO Participant Representative, FMC
  • Rohitkumar Vyas, MD
    Voting member
    ACO Participant Representative, FMC
  • Juan Cevallos, MD
    Voting member
    ACO Participant Representative, FMC
  • Gerald Curley, DO
    Voting member
    ACO Participant Representative, FMC
  • Belen Herrero, MD
    Voting member
    ACO Participant Representative, FMC
  • Richard Ina, MD
    Voting member
    ACO Participant Representative, FMC
  • Mitch Forman, MD
    Voting member
    ACO Participant Representative, FMC Urgent Care
  • Joe Delatorre, CEO
    Voting member
    Other representative
  • KEY ACO CLINICAL AND ADMINISTRATIVE LEADERSHIP

  • Joe Delatorre, CEO
    ACO Executive
  • Dr. Chandresh Saraiya,
    Medical Director
  • Eddine Luma,
    Compliance & HIPAA Privacy Officer
  • Dr. Emilio Dominguez,
    Chief Medical Director
  • ACO COMMITTEES & COMMITTEE LEADERSHIP

  • Quality and Performance Monitoring Committee

  • Nancy Finnerty, MD
    Chairman
  • Douglas Baska, DO
  • Crete Fisher, MD
  • Joseph Hubaykah, MD
  • Judyth Miranda, ARNP, Director of Accountable Care Organization
  • Tracy Mckay, MD
  • Richard McDonough, MD
  • Parag Pitroda, MD
  • Chandresh Saraiya, MD
  • Joel Sokolik, MD
  • Gabriel Somori, MD
  • Compliance Committee

  • Eddine Luma, Assoc. Director of Clinical Transformation & Compliance & HIPAA Privacy Officer
    Chairperson
  • Christian Alvarez, CFO
  • Samantha Champagnie, Senior Director
  • Joe Delatorre, CEO
  • Emilio Dominguez, MD
  • Judyth Miranda, ARNP, Director of Accountable Care Organization
  • Gus Taylor, CAO
  • Paula VanNorman, Sr. Director of Physician Offices
  • Community Relations Committee

  • Chandresh Saraiya, MD, FMC
    Chairman
  • Judyth Miranda, ARNP, ACO Director, FMC
  • Leigh Walker-Blankenship, ACO Manager, FMC
  • Sirisha Chalasani, MD, FMC
  • Jane Worden, RN Care Manager, FMC
  • Amy Wolfe, LPN Care Manager, FMC
  • Tanja Cogan, BSW, FMC
  • Evan Smith, Encompass Home Health
  • Alysia Dunwoody, RN, Encompass Home Health
  • Kathy Kondolf-Harmmer, Administrator, Heartland of Zephyrhills
  • Adam Timer, Heartland of Zephyrhills
  • Donna Coulter, DON, Royal Oaks
  • Jake Mitchell, Administrator, Royal Oaks
  • Rosemary Hartzner, Admissions Director, Royal Oaks
  • Payton Baker, Heritage Park
  • Lido Capogrosso, Admissions Director, Heritage Park
  • Pamela Cafra, Zephyrhills Health & Rehab
  • Karen Alvarez, CARES Home Health
  • Chandra Amin, Florida Hospital
  • Rey Basila, PT, Administrator, Mission Home Care
  • Geri Burke, Care Patrol
  • Debbie Densmore, North Tampa Behavioral Health
  • Crete Fisher, MD, FMC
  • Reginald Villaruel, RN, Director of Nursing, Mission Home Care

TYPES OF ACO PARTICIPANTS THAT FORMED THE ACO

A network of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Agreement period beginning 2012, Performance Year 1: $0

Agreement period beginning 2012, Performance Year 2014: $0

Agreement period beginning 2012, Performance Year 2015: $0

Shared Savings Distribution

Agreement period beginning 2012, Performance Year 1: $0

Agreement period beginning 2012, Performance Year 2014: $0

Agreement period beginning 2012, Performance Year 2015: $0

PAYMENT RULE WAIVERS

No, our ACO does not utilize the SNF 3-Day Rule Waiver.

Quality Performance Results

Click here to view 2015 Quality Report PDF

2012 Reporting Period 2013 Reporting Period 2014 Reporting Period
Measure number Performance Measure ACO Performance Rate Mean Performance Rate for All ACOs ACO Performance Rate Mean Performance Rate for All ACOs ACO Performance Rate Mean Performance Rate for All ACOs
ACO #1 Getting Timely Care, Appointments, and Information 78.12 81.69 78.7 81.48 77.59 80.13
ACO #2 How Well Your Doctors Communicate 88.73 92.84 91.72 92.96 91.46 92.39
ACO #3 Patients' Rating of Doctor 88.12 91.86 90.02 92.06 91.43 91.58
ACO #4 Access to Specialists 88.07 85.11 87.91 85.12 86.84 83.97
ACO #5 Health Promotion and Education 56.87 56.61 59.86 58.38 58.8 58.29
ACO #6 Shared Decision Making 72.57 73.99 75.57 74.53 75.06 74.6
ACO #7 Health Status/Functional Status 68.58 70.35 71.08 71.12 71.42 71.1
ACO #8 Risk Standardized, All Condition Readmissions 14.78 15.42 14.57 14.9 14.99 15.15
ACO #9 ASC Admissions: COPD or Asthma in Older Adults 0.9 1.13 1.07 1.17 0.85 1.08
ACO #10 ASC Admission: Heart Failure 1.33 1.09 1.26 1.2 1.26 1.19
ACO #11 Percent of PCPs who Qualified for EHR Incentive Payment 92.11% 25.70% 86.00% 66.21% 94.64% 76.71%
ACO #12 Medication Reconciliation 0.19 72.37 24.59 73.56 69.29 82.61
ACO #13 Falls: Screening for Fall Risk 2.3 28.27 45.67 39.57 58.54 45.6
ACO #14 Influenza Immunization 60.76 50.58 68.66 56.93 69.36 57.51
ACO #15 Pneumococcal Vaccination 47.39 48.62 64.82 54.76 58.01 55.03
ACO #16 Adult Weight Screening and Follow-up 81.04 53.91 71.29 61.61 86.2 66.75
ACO #17 Tobacco Use Assessment and Cessation Intervention 96.18 80.12 97.84 84.01 97.83 86.79
ACO #18 Depression Screening 0.23 22.48 38.75 31.19 56.2 39.27
ACO #19 Colorectal Cancer Screening 50.69 50.21 74.58 59.3 65.62 56.14
ACO #20 Mammography Screening 52.72 62.23 59.08 62.05 70.07 61.41
ACO #21 Proportion of Adults who had blood pressure screened in past 2 years 0 71.56 50.2 74.25 51.05 60.24
ACO #22 Hemoglobin A1c Control (HbA1c) (<8 percent) 80.74 N/A 86.33 N/A 82.73 N/A
ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) 57.31 N/A 63.31 N/A N/A N/A
ACO #24 Blood Pressure (BP) <140/90 73.09 N/A 74.34 N/A 66.91 N/A
ACO #25 Tobacco Non Use 88.86 N/A 90.17 N/A 88.08 N/A
ACO #26 Asprin Use 72.86 N/A 86.42 N/A 86.14 N/A
ACO #27 Percent of Beneficiaries with Diabetes whose HbA1c in poor control (>9 percent) 13.92% 25.94% 7.43% 22.11% 8.74% 20.35%
ACO #28 Percent of Beneficiaries with Hypertension whose BP <140/90 71.28% 63.22% 80.19% 67.79% 64.32% 68.02%
ACO #29 Percent of Beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl 59.04% 52.02% 64.90% 55.44% N/A N/A
ACO #30 Percent of Beneficiaries with IVD who use Asprin ir other Antithrombotic 79.08% 72.60% 84.76% 76.35% 86.49% 80.79%
ACO #31 Beta-Blocker Therapy for LVSD 70.83 79.60 90.79 79.82 88.89 82.71%
ACO #32 Drug Therapy for Lowering LDL Cholesterol 78.95 N/A 82.41 N/A N/A N/A
ACO #33 ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD 62.88 N/A 69.01 N/A 73.66 N/A

For more information on how to interpret scores on the above quality performance measures, see
https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/downloads/MSSP-QM-Benchmarks.pdf